Patents for C07D 211 - Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings (37,939) |
---|
06/02/2000 | WO2000031033A1 Piperidine ccr-3 receptor antagonists |
06/02/2000 | WO2000030638A1 Drugs and reagents containing n-acyloxylated cycloalkyl compounds as the active ingredient |
06/02/2000 | CA2351631A1 Piperidine quaternary salts-ccr-3 receptor antagonists |
05/31/2000 | EP1004581A2 Process for the preparation of thalidomide |
05/31/2000 | EP1004580A2 Imides as inhibitors of TNF alpha |
05/31/2000 | EP1004572A2 Amines as inhibitors of TNF alpha |
05/31/2000 | EP1004564A1 Process for the preparation of hydroxyethylcyclohexanes and hydroxyethylpiperidines |
05/31/2000 | EP1003743A1 3,3-disubstituted piperidines as modulators of chemokine receptor activity |
05/31/2000 | EP1003720A1 Aryloxyarylsulfonylamino hydroxamic acid derivatives |
05/31/2000 | EP1003541A1 Inhibitors of hiv reverse transcriptase |
05/31/2000 | EP1003540A1 $g(b)2-ADRENERGIC RECEPTOR AGONISTS |
05/31/2000 | EP1003514A1 Cyclic amine modulators of chemokine receptor activity |
05/31/2000 | EP1003513A1 Medicinal product and method for treatment and prevention of cognitive disorders |
05/31/2000 | EP1003511A1 ALPHA 1aADRENERGIC RECEPTOR ANTAGONISTS |
05/31/2000 | EP0868181B1 Use of alpha,alpha-diphenylacetic acid-4-(n-methyl-piperidyl)ester as anti-spasmodic |
05/31/2000 | DE19955340A1 CCR-3-Rezeptor-Antagonisten CCR-3 receptor antagonists |
05/31/2000 | CN1255122A Process for preparation of 1-alkyl-3-methylpiperidone-2 and 1-alkyl-5-methylpiperidone-2 |
05/31/2000 | CN1255119A Protease inhibitors |
05/31/2000 | CN1254596A Process for preparing composition to kill internal parasites |
05/30/2000 | US6069254 Carboxamide derivatives of piperidine for the treatment of thrombosis disorders |
05/30/2000 | US6069154 In humans; side effect reduction |
05/30/2000 | US6069143 Anticoagulants |
05/25/2000 | WO2000029377A1 4-aroyl-piperidin-ccr-3 receptor antagonists iii |
05/25/2000 | WO2000018361A3 Method of treating hair loss using sulfonamides |
05/25/2000 | DE19955793A1 CCR-3-Rezeptor-Antagonisten CCR-3 receptor antagonists |
05/25/2000 | DE19853858A1 Verfahren zur Herstellung von Hydroxyethylcyclohexanen und Hydroxyethylpiperidinen A process for preparing Hydroxyethylcyclohexanen and Hydroxyethylpiperidinen |
05/25/2000 | CA2350722A1 4-aroyl-piperidin-ccr-3 receptor antagonists iii |
05/24/2000 | EP1002794A1 4-[(Aryl)(aryloxy)methyl]piperidine derivatives and their use as serotonin and/or noradrenaline reuptake inhibitors |
05/24/2000 | EP1001930A2 N-hydroxyformamide derivatives as inhibitors of matrix metalloproteinases |
05/24/2000 | EP1001777A1 Fibrinogen receptor antagonists |
05/24/2000 | EP1001772A1 Improved delivery of multiple doses of medications |
05/24/2000 | EP1001771A1 A medicament against infertility and for increasing fertility |
05/24/2000 | EP1001766A1 Compounds and methods |
05/24/2000 | CN1254337A N-hydroxy 4-sulfonyl butyramide compounds |
05/23/2000 | US6066756 Phenylacetic acid derivatives, preparation thereof and intermediates therefor, and compositions containing them |
05/23/2000 | US6066737 Process for the preparation of optically enriched 4-aryl-3-hydromethyl substituted piperidines to be used as intermediates in the synthesis of paroxetine |
05/23/2000 | US6066666 Anticonvulsant and anxiolytic lactam and thiolactam derivatives |
05/23/2000 | US6066656 2,5-diamino-3,4-disubstituted-1,6-diphenylhexane isosteres comprising benzamide, sulfonamide and anthranilamide subunits and methods of using same |
05/23/2000 | US6066655 For the treatment of central nervous system disorders, in particular as cerebral therapeutics |
05/23/2000 | US6066654 Methods for treating disorders associated with the central nervous system using optically pure (-) cisapride |
05/23/2000 | US6066651 Antithrombotic agents by virtue of their ability to prevent platelet aggregation |
05/23/2000 | US6066650 Inhibitors of microsomal triglyceride transfer protein and method |
05/23/2000 | US6066642 For selectively blocking the a3 adenosine receptor of a mammal |
05/23/2000 | US6066636 Muscarinic antagonists |
05/23/2000 | US6066632 Heterocyclic compounds |
05/23/2000 | US6066490 Microorganisms that produces a hydrolase enzyme that demonstrates preferential activity |
05/23/2000 | CA2181089C Piperidine derivatives and process for their production |
05/23/2000 | CA2171637C Substituted azaheterocyclecarboxylic acids |
05/23/2000 | CA2010578C Piperidine compounds and their preparation and use |
05/18/2000 | WO2000027820A1 N-aryl(thio)anthranilic acid amide derivatives, their preparation and their use as vegf receptor tyrosine kinase inhibitors |
05/18/2000 | WO2000027815A2 N-substituted azacycles, their preparation and their use as orl-1 receptor ligands |
05/18/2000 | WO2000027812A1 Phenyl-substituted cyclic enaminones |
05/18/2000 | WO2000027795A1 Transfection reagents |
05/18/2000 | WO2000009479A3 Heterocyclic thioesters or ketones for vision and memory disorders |
05/18/2000 | DE19851986A1 Phenyl-substituierte zyklische Enaminone Phenyl-substituted cyclic enaminones |
05/18/2000 | CA2350305A1 Phenyl-substituted cyclic enaminones |
05/18/2000 | CA2346898A1 N-aryl(thio)anthranilic acid amide derivatives, their preparation and their use as vegf receptor tyrosine kinase inhibitors |
05/17/2000 | EP1000085A1 Treatment of insulin resistance with growth hormone secretagogues |
05/17/2000 | EP1000048A1 Substituted 1,2,3,4-tetrahydronaphthalene derivatives |
05/17/2000 | EP1000032A1 Inhibition of pulp and paper yellowing using nitroxides and other coadditives |
05/17/2000 | EP1000030A1 Piperidine oligomers and combinatorial libraries thereof |
05/17/2000 | EP1000029A1 (+)-norcisapride useful for 5-ht3 and 5-ht4 mediated disorders |
05/17/2000 | EP1000028A1 Gastrokinetic monocyclic benzamides of 3- or 4-substituted 4-(aminomethyl)-piperidine derivatives |
05/17/2000 | EP1000023A2 Novel nitric oxide-releasing amidine- and enamine-derived diazeniumdiolates, compositions and uses thereof and method of making same |
05/17/2000 | EP0912090A4 Insecticidal n-(substituted arylmethyl)-4- bis(substituted aryl) hydroxymethyl]piperidinium salts |
05/17/2000 | EP0770066B1 Serotonin 5-ht 1a and dopamin d2 receptor ligands |
05/17/2000 | EP0726768B1 Use of nitric oxide releasing compounds for the manufacture of a medicament for protection in ischemia reperfusion injury |
05/17/2000 | CN1253559A Sulfonyl divalent aryl alpha-hydroxamic acid compounds |
05/17/2000 | CN1253547A 1,4-substituted cyclic amine derivatives |
05/17/2000 | CN1253474A Sulfonyl divalent aryl or heteroaryl hydroxamic acid compounds |
05/17/2000 | CN1253019A Method for preparing medicine composition capable of inhibiting post infective virus proteinase |
05/16/2000 | US6063926 Having greater bioactivity |
05/16/2000 | US6063816 Hydroxamic acid compounds |
05/16/2000 | US6063793 Antiserotonin agents, psychological disorders and treatment of schizophrenia |
05/16/2000 | CA2176971C Preparation of cisapride |
05/11/2000 | WO2000026332A1 Washing and cleaning method |
05/11/2000 | WO2000026189A1 Method for producing nitroxyl compounds of secondary amines |
05/11/2000 | WO2000026188A1 Cycloheximide derivatives which influence the regeneration of neural tissue |
05/11/2000 | WO2000026187A1 Process for producing 4-arylpiperidine-3-carbinols and related compounds |
05/11/2000 | WO2000025786A1 Heterocyclic potassium channel inhibitors |
05/11/2000 | WO2000025782A1 Dihydropyridinones and pyrrolinones useful as alpha 1a adrenoceptor antagonists |
05/11/2000 | WO2000025776A1 Nitrosated and nitrosylated nonsteroidal antiinflammatory compounds, compositions and methods of use |
05/11/2000 | WO2000009110A3 N-linked urea or carbamate of heterocyclic thioesters for vision and memory disorders |
05/11/2000 | CA2348555A1 Washing and cleaning method |
05/10/2000 | EP0999220A2 Low molecular weight peptidomimetic growth hormone secretagogues |
05/10/2000 | EP0998469A1 Benzamide cycloalkyl stimulating high and low gastrointestinal motricity |
05/10/2000 | EP0998458A1 Novel benzamide derivatives stimulating high and low gastrointestinal motricity |
05/10/2000 | EP0998451A1 Substituted 3,3-diamino-2-propenenitriles, their preparation and use |
05/10/2000 | EP0998286A2 Use of levobupivacaine |
05/10/2000 | EP0743939B1 Aralkoxy and aralkylthio substituted azacyclic compounds as tachykinin antagonists |
05/10/2000 | EP0685234B1 Drug composition containing nucleic acid copolymer |
05/10/2000 | CN1252803A Herbicidal sulfonamides |
05/10/2000 | CN1252790A N-hydroxy-2-(alkyl, aryl or heteroaryl sulfanyl, sulfinyl or sulfonyl)-3-substituted alkyl, aryl or heteroarylamides as matrix metalloproteinase inhibitors |
05/10/2000 | CN1252713A N-hydroxy-2-(alkyl, aryl or heteroaryl sulfanyl, sulfinyl or sulfonyl)-3-substituted alkyl, aryl or heteroarylamides as matrix metalloproteinase inhibitors |
05/10/2000 | CN1052240C Method for preparing inhibitor of retroinfection viral protease |
05/10/2000 | CN1052224C Piperidine derivatives, peripheral vasodilating agent containing it, and its use |
05/09/2000 | US6060513 Compounds and compositions for delivering active agents |
05/09/2000 | US6060485 Arylacetic amide derivative or salt thereof, and pharmaceutical comprising it |
05/09/2000 | US6060476 α- and β-amino acid hydroxyethylamino sulfonamides useful as retroviral protease inhibitors |
05/09/2000 | CA2084412C Pyrrolidine and thiazolidine amides |